Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-14 Option Award | 2023-07-05 5:48 pm | N/A 2033-06-14 | Chemomab Therapeutics Ltd. | CMMB | Darvish Nissim Director | 56,256 | $0 | 57,456 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-20 06:03 am | N/A 2033-06-16 | Chemomab Therapeutics Ltd. | CMMB | Quigley Jill M. Director | 20,497 | $0 | 34,137 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 4:03 pm | N/A 2033-06-14 | Chemomab Therapeutics Ltd. | CMMB | Fatal Sigal Chief Financial Officer | 167,860 | $0 | 273,669 (Direct) | View |
Ownership | 2023-06-05 4:54 pm | N/A N/A | Chemomab Therapeutics Ltd. | CMMB | Fatal Sigal Chief Financial Officer | 0 | $0 | 70,209 (Direct) | View |
| 2023-03-16 Option Award | 2023-03-23 07:38 am | N/A 2033-03-21 | Chemomab Therapeutics Ltd. | CMMB | Moses Alan Charles Director | 25,561 | $0 | 25,561 (Direct) | View |
| 2023-03-16 Option Award | 2023-03-23 07:36 am | N/A 2033-03-21 | Chemomab Therapeutics Ltd. | CMMB | Nicaise Claude Director | 25,561 | $0 | 25,561 (Direct) | View |
| 2023-03-16 Option Award | 2023-03-23 07:35 am | N/A 2033-03-21 | Chemomab Therapeutics Ltd. | CMMB | Cohen Neil Harris Director | 26,267 | $0 | 36,267 (Direct) | View |
| 2023-03-16 Option Award | 2023-03-23 07:33 am | N/A 2033-03-21 | Chemomab Therapeutics Ltd. | CMMB | Darvish Nissim Director | 35,684 | $0 | 36,884 (Direct) | View |
| 2018-03-15 Option Award | 2023-01-05 4:01 pm | N/A 2028-03-15 | Chemomab Therapeutics Ltd. | CMMB | Mor George Adi Chief Scientific Officer | 165,423 | $0 | 733,645 (Direct) | View |
| 2022-03-07 Option Award | 2022-11-18 07:53 am | N/A 2032-03-07 | Chemomab Therapeutics Ltd. | CMMB | Cohen Neil Harris Director | 19,392 | $0 | 29,392 (Direct) | View |
| 2018-03-15 Option Award | 2022-11-17 4:56 pm | N/A 2028-03-15 | Chemomab Therapeutics Ltd. | CMMB | Mor George Adi Chief Scientific Officer | 165,423 | $0 | 747,445 (Direct) | View |
Ownership | 2022-11-15 4:03 pm | N/A 2032-11-14 | Chemomab Therapeutics Ltd. | CMMB | Frankel Matthew Bejosa Chief Medical Officer | 0 | $0 | 125,000 (Direct) | View |
Ownership | 2022-06-21 07:15 am | N/A 2032-06-16 | Chemomab Therapeutics Ltd. | CMMB | Quigley Jill M. Director | 0 | $0 | 13,640 (Direct) | View |
| 2021-11-08 Option Award | 2022-06-21 06:01 am | N/A 2021-11-08 | Chemomab Therapeutics Ltd. | CMMB | Marvin Donald Executive VP, CFO & COO | 196,875 | $0 | 198,875 (Direct) | View |
| 2022-03-07 Option Award | 2022-05-25 4:03 pm | N/A 2032-03-07 | Chemomab Therapeutics Ltd. | CMMB | Maryles Joel Michael Director | 18,704 | $0 | 20,137 (Direct) | View |
| 2022-03-07 Option Award | 2022-05-19 4:02 pm | N/A 2032-03-07 | Chemomab Therapeutics Ltd. | CMMB | Cohen Neil Harris Director | 19,392 | $0 | 31,801 (Direct) | View |
| 2022-03-07 Option Award | 2022-03-21 06:04 am | N/A 2032-03-07 | Chemomab Therapeutics Ltd. | CMMB | Maryles Joel Michael Director | 18,704 | $0 | 19,704 (Direct) | View |
| 2021-11-08 Option Award | 2022-03-21 06:02 am | N/A 2021-11-08 | Chemomab Therapeutics Ltd. | CMMB | Marvin Donald Executive VP, CFO & COO | 196,875 | $0 | 198,375 (Direct) | View |
| 2021-10-25 Option Award | 2022-03-15 4:10 pm | N/A 2031-10-25 | Chemomab Therapeutics Ltd. | CMMB | Pfost Dale R Chief Executive Officer | 459,353 | $0 | 461,853 (Direct) | View |
| 2022-03-07 Option Award | 2022-03-15 4:07 pm | N/A 2032-03-07 | Chemomab Therapeutics Ltd. | CMMB | Cohen Neil Harris Director | 19,392 | $0 | 29,801 (Direct) | View |
| 2022-03-07 Option Award | 2022-03-14 4:20 pm | N/A 2032-03-07 | Chemomab Therapeutics Ltd. | CMMB | Darvish Nissim Director | 28,827 | $0 | 30,027 (Direct) | View |
| 2022-03-07 Option Award | 2022-03-09 4:08 pm | N/A 2032-03-07 | Chemomab Therapeutics Ltd. | CMMB | Darvish Nissim Director | 18,704 | $0 | 28,827 (Direct) | View |
| 2022-03-07 Option Award | 2022-03-09 4:07 pm | N/A 2032-03-07 | Chemomab Therapeutics Ltd. | CMMB | Nicaise Claude Director | 18,704 | $0 | 18,704 (Direct) | View |
| 2022-03-07 Option Award | 2022-03-09 4:05 pm | N/A 2032-03-07 | Chemomab Therapeutics Ltd. | CMMB | Cohen Neil Harris Director | 6,820 | $0 | 23,801 (Direct) | View |
| 2022-03-07 Option Award | 2022-03-09 4:04 pm | N/A 2032-03-07 | Chemomab Therapeutics Ltd. | CMMB | Moses Alan Charles Director | 18,704 | $0 | 18,704 (Direct) | View |
| 2022-03-07 Option Award | 2022-03-09 4:01 pm | N/A 2032-03-07 | Chemomab Therapeutics Ltd. | CMMB | Maryles Joel Michael Director | 18,704 | $0 | 18,704 (Direct) | View |
Ownership | 2021-11-12 06:17 am | N/A 2031-11-08 | Chemomab Therapeutics Ltd. | CMMB | Marvin Donald Executive VP, CFO & COO | 0 | $0 | 196,875 (Direct) | View |
Ownership | 2021-11-04 4:12 pm | N/A 2031-10-25 | Chemomab Therapeutics Ltd. | CMMB | Pfost Dale R Chief Executive Officer | 0 | $0 | 459,353 (Direct) | View |
| 2021-05-07 Option Award | 2021-05-10 4:01 pm | N/A 2031-05-07 | Chemomab Therapeutics Ltd. | CMMB | Fatal Sigal Chief Financial Officer | 35,653 | $0 | 35,653 (Direct) | View |
| 2021-04-19 Option Award | 2021-04-21 5:16 pm | N/A 2031-04-19 | Chemomab Therapeutics Ltd. | CMMB | SQUINTO STEPHEN P Director | 23,768 | $0 | 168,624 (Direct) | View |
| 2021-04-19 Option Award | 2021-04-21 5:16 pm | N/A 2031-04-19 | Chemomab Therapeutics Ltd. | CMMB | Nicaise Claude Director | 11,884 | $0 | 11,884 (Direct) | View |
| 2021-04-19 Option Award | 2021-04-21 5:15 pm | N/A 2031-04-19 | Chemomab Therapeutics Ltd. | CMMB | Moses Alan Charles Director | 11,884 | $0 | 11,884 (Direct) | View |
| 2021-04-19 Option Award | 2021-04-21 5:11 pm | N/A 2031-04-19 | Chemomab Therapeutics Ltd. | CMMB | Maryles Joel Michael Director | 11,884 | $0 | 11,884 (Direct) | View |
| 2021-04-19 Option Award | 2021-04-21 5:09 pm | N/A 2031-04-19 | Chemomab Therapeutics Ltd. | CMMB | Darvish Nissim Director | 11,884 | $0 | 22,007 (Direct) | View |
| 2021-04-19 Option Award | 2021-04-21 5:06 pm | N/A 2031-04-19 | Chemomab Therapeutics Ltd. | CMMB | Cohen Neil Harris Director | 11,884 | $0 | 14,981 (Direct) | View |
Ownership | 2021-03-26 4:02 pm | N/A N/A | Chemomab Therapeutics Ltd. | CMMB | OrbiMed Israel GP Ltd. OrbiMed Israel BioFund GP Limited Partnership 10% Owner | 0 | $0 | 2,290,004 (Indirect) | View |